Diamyd expands the team in Umeå for upscaled production of technical batches
Diamyd Medical is expanding its workforce in Umeå, hiring individuals with key competencies for the production of technical batches of recombinant GAD65 protein. The company's biomanufacturing facility in Umeå is established for the production of Diamyd, currently being evaluated in a Phase III clinical trial for preserving insulin production.